Rajeev Dhere

1.5k total citations
60 papers, 868 citations indexed

About

Rajeev Dhere is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Rajeev Dhere has authored 60 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 20 papers in Infectious Diseases and 11 papers in Microbiology. Recurrent topics in Rajeev Dhere's work include Pneumonia and Respiratory Infections (17 papers), Virology and Viral Diseases (15 papers) and Influenza Virus Research Studies (11 papers). Rajeev Dhere is often cited by papers focused on Pneumonia and Respiratory Infections (17 papers), Virology and Viral Diseases (15 papers) and Influenza Virus Research Studies (11 papers). Rajeev Dhere collaborates with scholars based in India, United States and United Kingdom. Rajeev Dhere's co-authors include Prasad S. Kulkarni, Subhash V. Kapre, S. S. Jadhav, Heikki Peltola, Mikko Paunio, Sambhaji S. Pisal, Suresh Jadhav, Bhagwat Gunale, Ravi Menon and Mark R. Alderson and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Rajeev Dhere

56 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rajeev Dhere India 16 500 339 168 122 119 60 868
Brandon Essink United States 15 397 0.8× 622 1.8× 119 0.7× 225 1.8× 69 0.6× 37 1.1k
John Treanor United States 8 790 1.6× 264 0.8× 76 0.5× 120 1.0× 54 0.5× 8 1.0k
David Featherstone Switzerland 18 771 1.5× 406 1.2× 314 1.9× 48 0.4× 20 0.2× 28 1.0k
Doris Chibo Australia 17 578 1.2× 461 1.4× 68 0.4× 57 0.5× 18 0.2× 36 894
Lucy Breakwell United States 13 348 0.7× 254 0.7× 58 0.3× 78 0.6× 116 1.0× 20 659
Michel Janssens Belgium 16 364 0.7× 284 0.8× 52 0.3× 234 1.9× 34 0.3× 32 973
Kimberly B. Hummel United States 12 714 1.4× 500 1.5× 98 0.6× 131 1.1× 17 0.1× 15 1.0k
Rachel Truscon United States 14 1.3k 2.6× 388 1.1× 128 0.8× 176 1.4× 30 0.3× 22 1.4k
Dubravko Forčić Croatia 18 549 1.1× 332 1.0× 41 0.2× 294 2.4× 19 0.2× 72 946
Xiaohong Song China 13 146 0.3× 337 1.0× 41 0.2× 241 2.0× 27 0.2× 36 709

Countries citing papers authored by Rajeev Dhere

Since Specialization
Citations

This map shows the geographic impact of Rajeev Dhere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajeev Dhere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajeev Dhere more than expected).

Fields of papers citing papers by Rajeev Dhere

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajeev Dhere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajeev Dhere. The network helps show where Rajeev Dhere may publish in the future.

Co-authorship network of co-authors of Rajeev Dhere

This figure shows the co-authorship network connecting the top 25 collaborators of Rajeev Dhere. A scholar is included among the top collaborators of Rajeev Dhere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajeev Dhere. Rajeev Dhere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gunale, Bhagwat, Nicholas Farinola, Chandrashekhar D. Kamat, et al.. (2024). An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia. The Lancet Infectious Diseases. 24(6). 639–649. 8 indexed citations
2.
Gunale, Bhagwat, Nicholas Farinola, Shubham Shrivastava, et al.. (2023). A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults. Vaccine. 41(38). 5614–5621. 2 indexed citations
3.
4.
Shandil, Radha Krishan, et al.. (2023). A Live Attenuated COVID-19 Candidate Vaccine for Children: Protection against SARS-CoV-2 Challenge in Hamsters. Vaccines. 11(2). 255–255. 9 indexed citations
5.
Dhere, Rajeev, et al.. (2023). Evaluation of structural modification induced activation of pneumococcal polysaccharide by GC-MS for the conjugate vaccine. Carbohydrate Research. 531. 108878–108878. 2 indexed citations
6.
Dhere, Rajeev, et al.. (2023). Acid hydrolysis conditions for quantification of meningococcal X polysaccharide in a pentavalent vaccine using HPAEC-PAD/ESI-MS. Analytical Biochemistry. 683. 115363–115363. 1 indexed citations
7.
Tyagi, Parikshit, Milan Ganguly, Sunil Gairola, et al.. (2022). Neurovirulence, viscerotropism and immunogenicity of live attenuated yellow fever 17D vaccine virus in non-human primates. Vaccine. 41(3). 836–843. 2 indexed citations
8.
Jana, Swapan Kumar, et al.. (2022). Partial depolymerization of capsular polysaccharides isolated from Streptococcus pneumoniae serotype 2 by various methods. Carbohydrate Research. 512. 108503–108503. 3 indexed citations
9.
Jana, Swapan Kumar, et al.. (2022). Purification of capsular polysaccharides isolated from S. pneumoniae serotype 2 by hydrogen peroxide and endonuclease. Carbohydrate Polymers. 294. 119783–119783. 5 indexed citations
10.
Kodam, Kisan M., et al.. (2021). Simultaneous purification and depolymerization of Streptococcus pneumoniae serotype 2 capsular polysaccharides by trifluoroacetic acid. Carbohydrate Polymers. 261. 117859–117859. 10 indexed citations
11.
Dhere, Rajeev, et al.. (2020). Evaluation of a sensitive GC–MS method to detect polysorbate 80 in vaccine preparation. Journal of Pharmaceutical and Biomedical Analysis. 183. 113126–113126. 6 indexed citations
12.
Kulkarni, Prasad S., et al.. (2020). Development of competitive inhibition ELISA as an effective potency test to analyze human rabies vaccines and assessment of the antigenic epitope of rabies glycoprotein. Journal of Immunological Methods. 492. 112939–112939. 6 indexed citations
13.
Ganguly, Milan, et al.. (2020). Evaluation of manufacturing feasibility and safety of an MDCK cell-based live attenuated influenza vaccine (LAIV) platform. Vaccine. 38(52). 8379–8386. 7 indexed citations
14.
Guilfoyle, Kate, Milan Ganguly, Parikshit Tyagi, et al.. (2020). Immunogenicity and efficacy comparison of MDCK cell-based and egg-based live attenuated influenza vaccines of H5 and H7 subtypes in ferrets. Vaccine. 38(40). 6280–6290. 8 indexed citations
15.
16.
Low, Nicola, Ashish Bavdekar, Lakshmanan Jeyaseelan, et al.. (2015). A Randomized, Controlled Trial of an Aerosolized Vaccine against Measles. New England Journal of Medicine. 372(16). 1519–1529. 62 indexed citations
17.
Mallajosyula, Vamsee, et al.. (2013). Isolation of a High Affinity Neutralizing Monoclonal Antibody against 2009 Pandemic H1N1 Virus That Binds at the ‘Sa’ Antigenic Site. PLoS ONE. 8(1). e55516–e55516. 15 indexed citations
18.
Dhere, Rajeev, Prasad S. Kulkarni, Ravi Menon, et al.. (2011). A pandemic influenza vaccine in India: From strain to sale within 12 months. Vaccine. 29. A16–A21. 47 indexed citations
19.
Sharma, Hitt, et al.. (2010). No demonstrable association between the Leningrad–Zagreb mumps vaccine strain and aseptic meningitis in a large clinical trial in Egypt. Clinical Microbiology and Infection. 16(4). 347–352. 8 indexed citations
20.
Kulkarni‐Kale, Urmila, et al.. (2006). Mapping antigenic diversity and strain specificity of mumps virus: A bioinformatics approach. Virology. 359(2). 436–446. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brandon Essink Breakdown of academic impact, for papers by John Treanor Breakdown of academic impact, for papers by David Featherstone Breakdown of academic impact, for papers by Doris Chibo Breakdown of academic impact, for papers by Lucy Breakwell Breakdown of academic impact, for papers by Michel Janssens Breakdown of academic impact, for papers by Kimberly B. Hummel Breakdown of academic impact, for papers by Rachel Truscon Breakdown of academic impact, for papers by Dubravko Forčić Breakdown of academic impact, for papers by Xiaohong Song
Rankless by CCL
2026